• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.33% Nasdaq Up1.33%

    More On TLB.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    TearLab Corporation (TLB.TO)

    -Toronto
    0.86 0.00(0.00%) Jun 28, 3:21PM EDT
    ProfileGet Profile for:
    TearLab Corporation
    9980 Huennekens Street
    Suite 100
    San Diego, CA 92121
    United States - Map
    Phone: 858-455-6006
    Fax: 858-812-0540
    Website: http://www.tearlab.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:118

    Business Summary 

    TearLab Corp. operates as an in-vitro diagnostic company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TearLab Corporation

    Key Executives 
     PayExercised
    Mr. Elias Vamvakas , 57
    Exec. Chairman
    351.00K0.00
    Mr. Joseph S. Jensen , 44
    Chief Exec. Officer, Pres and Director
    491.00K0.00
    Mr. Wes Brazell , 50
    Chief Financial Officer
    203.00K0.00
    Dr. Richard L. Lindstrom M.D., 68
    Scientific Advisor, Director and Chairman of Compensation Committee
    36.00KN/A
    Dr. Paul M. Karpecki OD, FAAO, 49
    Scientific Advisor, Director, Member of Clinical Advisory Board and Member of Corp. Governance & Nominating Committee
    36.00KN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.